Hypertensive left ventricular hypertrophy: Pathophysiology, assessment and treatment

Blood Pressure

Volumn 5, Issue 1, 1996, Pages 5-15

  Otterstad, Jan Erik ^a   Smiseth, Otto ^b   Kjeldsen, Sverre Erik ^c  

^a Division of Cardiology   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Hypertension; Left ventricular hypertrophy

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ELECTROCARDIOGRAM; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; M MODE ECHOCARDIOGRAPHY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; THREE DIMENSIONAL IMAGING; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 0029883806     PISSN: 08037051     EISSN: None     Source Type: Journal    
DOI: 10.3109/08037059609062101     Document Type: Review

References (88)

1. Kannel WB. Prevalence and natural history of electrocardiographic left ventricular hypertrophy. Am J Med 1983; 75 (Suppl 3A): 4-11.
2. Levy D. Garrison RJ, Savage DD, Kannel WB, Casteli WP. Left ventricular mass and incidence of coronary heart disease in an elderly corhort. The Framingham Heart Study. Ann Intern Med 1989; 110: 101-7.
3. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561-6.
4. Kannel WB. Left ventricular hypertrophy as a risk factor: the Framingham experience. J Hypertens 1991; 9 (Suppl 2): S3-9.
5. Casale PN, Devereux RB, Milner M, et al. Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 1986; 105: 173-8.
6. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114: 345-52.
7. Bikkina M, Levy D, Evans JC, et al. Left ventricular mass and risk of stroke in an elderly cohort. The Framingham Heart Study. JAMA 1994; 272: 33-6.
8. Pichard AD, Gorlin R, Smith H, Ambrose J, Meller J. Coronary flow studies in patients with left ventricular hypertrophy of the hypertensive type. Am J Cardiol 1981; 47: 547-54.
9. Marcus ML, Harrison DG, Chilian WM, et al. Alterations in the coronary circulation in hypertrophied left ventricles. Circulation 1987; 75(Suppl I): I-19-25.
10. Houghton JL, Frank MJ, Carr AA, von Dohlen TW, Prisant M. Relations among impaired coronary flow reserve, left ventricular hypertrophy and thallium perfusion defects in hypertensive patients without obstructive coronary artery disease. J Am Coll Cardiol 1990; 15: 43-51.
11. Strauer BE, Schwartzkopff B, Motz W, Vogt M. Coronary vascular changes in the progression and regression of hypertensive heart disease. J Cardiovasc Pharmacol 1991; 18(Suppl): S20-27.
12. McLenachan JM, Henderson E, Morris KL, Dargie HJ. Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy. N Engl J Med 1987; 317: 787-92.
13. Garan H. Vulnerability to ischemic ventricular arrhythmias in left ventricular hypertrophy. Editorial comment. J Am Coll Cardiol 1989; 14: 1374-5.
14. Varizi SM, Larson MG, Benjamin EJ, Levy D. Echocardiographic predictors of nonrheumatic atrial fibrillation The Framingham Heart Study. Circulation 1994; 89: 724-30.
15. White WB, Schulman P, McCabe EJ, Day HM. Average daily blood pressure, not office blood pressure, determines cardiac function in patients with hypertension. JAMA 1989; 261: 873-7.
16. Culpepper WS, Sodt PC, Messerli F, Ruschaupt DG, Arcilla RA. Cardiac status in juvenile hypertension. Ann Intern Med 1983; 98: 1-7.
17. Radice M, Alli C, Avanzani F, et al. Left ventricular structure and function in normotensive adolescents with a genetic predisposition to hypertension. Am Heart J 1986; 111: 115-20.
18. Roman MJ, Sergio Saba P, Pini R, et al. Parallel cardiac and vascular adaption in hypertension. Circulation 1992; 86: 1909-18.
19. Roman MJ, Pickering TG, Schwartz JE, Pini R, Devereux RB. Association of carotid arteriosclerosis and left ventricular hypertrophy. J AM Coll Cardiol 1995; 25: 83-90.
20. Weber KT, Brilla CG. Structural basis for pathologic left ventricular hypertrophy. Clin Cardiol 1993; 16(Suppl 2): II-10-14.
21. Weber KT, Brilla CG, Janicki JS, Reddy HK, Campbell SE. Myocardial fibrosis: role of ventricular systolic pressure, arterial hypertension, and circulating hormones. Basic Res Cardiol 1991; 86(Suppl): 25-31.
22. Weber KT, Anversa P, Armstrong PW, et al. remodelling and reparation of the cardiovascular system. Review article. J Am Coll Cardiol 1992; 20: 3-16.
23. Rostrup M, Smith G, Bjørnstad H, Westheim A, Stokland O, Eide I. Left ventricular mass and cardiovascular reactivity in young men. Hypertension 1994; 23 (Suppl 1): I-68-71.
24. Strauer BE, Mahmoud MA. Coronary hemodynamics in hypertensive heart disease: basic concepts and clinical consequences. J Cardiovasc Pharmacol 1985; 7 (Suppl 2): S62-9.
25. Tanaka M, Fujiwara H, Onodera T, et al. Quantitative analysis of narrowings of intramyocardial small arteries in normal hearts, hypertensive hearts, and hearts with hypertrophic cardiomyopathy. Circulation 1987; 75: 1130-9.
26. Schwartzkopff B, Motz W, Frenzel H, Vogt M, Knauer S, Strauer BE. Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension. Circulation 1993; 88: 993-1003.
27. Strauer BE. Ventricular function and coronary hemodynamics in hypertensive heart disease. Am J Cardiol 1979; 44: 999-1006.
28. Motz W, Vogt M, Rabenau O, Scheler S, Lückhoff, Strauer BE. Evidence of endothelial dysfunction in coronary resistance vessels in patients with angina pectoris and normal coronary angiograms. Am J Cardiol 1991; 68: 996-1003.
29. Anderson KP. Sudden death, hypertension and hypertrophy. J Cardiovasc Pharmacol 1984; 6: S498-502.
30. Mandrawat MK, Wallbridge DR, Pringle SD, et al. Heart rate variability in left ventricular hypertrophy. Br Heart J 1995; 73: 139-44.
31. Levy D, Labib SB, Anderson KM, Christiansen JC, Kannel WB, Castelli WP. Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation 1990; 81: 815-20.
32. Otterstad JE, Froeland G, Wasenius AK, Knutsen KM, Michelsen S, Stugaard M. Validity of the ECG diagnosis of left ventricular hypertrophy in normotensive and moderately hypertensive men when using the echocardiographic assessment of left ventricular mass index as reference. J Hum Hypertens 1991; 5: 101-6.
33. Devereux RB. Is the electrocardiogram still useful for detection of left ventricular hypertrophy? Editorial comment. Circulation 1990; 81: 1144-6.
34. Otterstad JE, Davies M, Ball SG, et al. Left ventricular hypertrophy and myocardial ischemia in hypertension: The THAMES Study. Eur Heart J 1993; 14: 1622-8.
35. Clement DL, DeBuyzere M, Duprez D. Left ventricular function and regression of left ventricular hypertrophy in essential hypertension. Am J Hypertens 1993; 6(Suppl): I4S-9.
36. Savage DD, Garrison RJ, Kannel WB, et al. The spectrum of left ventricular hypertrophy in a general population sample: The Framingham Study. Circulation 1987: 75(Suppl I): I-26-33.
37. Devereux RB, Lutas EM, Casale PN, et al. Standardization of M-mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol 1984; 4: 1222-30.
38. Knutsen KM, Stugaard M, Michelsen S, Otterstad JE. M-mode echocardiographic findings in apparently healthy, non-athletic Norwegians aged 20-70 years. Influence of age, sex and body surface area. J Intern Med 1989; 225: 111-5.
39. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Circulation 1977; 55: 613-8.
40. Reichek N, Devereux RB. Left ventricular hypertrophy: relationship of anatomic, echocardiographic and electrocardiographic findings. Circulation 1981; 63: 1391-8.
41. Sahn DJ, DeMaria A, Kisslo J, et al. Recommendations regarding quantitation of M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978; 58: 1072-83.
42. Reichek N, Devereux RB. Reliable estimation of peak left ventricular systolic pressure by M-mode echocardiographic-determined end-diastolic relative wall thickness: identification of severe valvular stenosis in adult patients. Am Heart J 1982; 103: 202-9.
43. Wallerson DC, Devereux RB. Reproducibility of quantitative echocardiography: factors affecting variability of imaging and Doppler measurements. Echocardiography 1986; 3: 219-31.
44. Reichek N, Helak J, Plappert T, St. John Sutton M, Weber KT. Anatomic validation of left ventricular mass estimates from clinical two-dimensional echocardiography: initial results. Circulation 1983; 67: 348-52.
45. Schiller NB, Skioldebrand C, Schiller E, et al. Canine left ventricular mass estimated by two-dimensional echocardiography. Circulation 1983; 68: 210-6.
46. Byrd BF III, Wahr D, Wang Y, Bouchard A, Schiller NB. Left ventricular mass and volume/mass ratio determined by two-dimensional echocardiography in normal adults. J Am Coll Cardiol 1985; 6: 1021-5.
47. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiogrsphy. J Am Soc Echocardiogr 1989; 2: 358-68.
48. Helak JW, Reichek N. Quantitation of human left ventricular mass and volume by two-dimensional echocardiography: in vitro anatomical validation. Circulation 1981; 63: 1398-407.
49. Liebson PR, Savage DD. Echocardiography in hypertension: a review. I. Left ventricular wall mass, standardization and ventricular function. Echocardiography 1986; 3: 181-218.
50. King DL, Copal AS, Kelller AM, Sapin PM, Schröder KM. Three-dimensional echocardiography. Advances for measurement of ventricular volume and mass. Hypertension 1994; 23 (Suppl I): I-182-89.
51. Dianzumba SB, DiPette DJ, Cornman C, Weber E, Joyner CR. Left ventricular filling characteristics in mild untreated hypertension. Hypertension 1986; 8 (Suppl I): I-156-60.
52. Cuocolo A, Sax FL, Brush JE, Baron BJ, Bacharach SL, Bonow RO. Left ventricular hypertrophy and impaired diastolic filling in essential hypertension. Diastolic mechanism for systolic dysfunction during exercise. Circulation 1990; 81: 978-86.
53. Pearson AC, Pasierski T, Labovitz AJ. Left ventricular hypertrophy: diagnosis, pronosis and management. Am Heart J 1991; 121: 148-57.
54. Fouad-Tarazi FM. Left ventricular diastolic function in hypertensin. Curr Opin Cardiol 1994; 9: 551-60.
55. Skagseth E. Pulmonary vein flow pattern in man during thoracotomy. Scand J Thorac Cardiovasc Surg 1976; 10: 36-42.
56. Smiseth OA, Lødemel K, Riddervold F, Blaha M. Changes in pulmonary vein flow pattern during volume loading. Cardiovasc Res 1993; 27: 411-5.
57. Nishimura RA, Abel MD, Hatle L, Tajik AJ. Relation of pulmonary vein to mitral flow velocities by transoesophageal Doppler echocardiography. Effect of different loading conditions. Circulation 1990; 81: 1488-97.
58. Rossvold O, Hatle L. Pulmonary venous flow velocities recforded by transthoracic Doppler ultrasound: relation to left ventricular diastolic pressures. J Am Coll Cardiol 1993; 21: 1687-96.
59. Myreng Y, Smiseth OA. Assessment of left ventricular relaxation by Doppler echocardiography: a comparison of isovolumic relaxation time and transmitral flow velocities with the time constant of isovolumic relaxation. Circulation 1990; 81: 260-6.
60. Myreng Y, Smiseth OA, Risøe C. Left ventricular filling at elevated diastolic pressures: relationship between transmitral Doppler flow velocities and atrial contribution. Am Heart J 1990; 119: 620-6.
61. Topol EJ, Traill, Fortun NJ. Hypertensive hypertrophic cardiomyopathy of the elderly. N Engl J Med 1985; 312: 277-83.
62. Eichstädt H, Mertens D, Schröder R, Richter W, Kreuz D. Linksventrikuläre Hypertrophie-Regression unter Lisinopril-Therapie bei Patienten mit leichter bis mittelsschwerer Hypertonie. Perfusion 1991; 4: 340-2.
63. Eichstädt HW, Felix R, Langer M, et al. Use of nuclear magnetic resonance imaging to show regression of hypertrophy with ramipril treatment. Am J Cardiol 1987; 59: 98D-103.
64. Motz W, Vogt M, Strauer BE. Therapeutical effects of chronic ACE-inhibition on coronary microcirculation and left ventricular hypertrophy. Parm Pharmacol Lett 1993; 3(suppl): 82-4.
65. Motz W, Vogt M, Scheler S, Schwartzkopff B, Strauer BE. Verbesserung der Koronarreserve nach Hypertrophieregression durch blutdrucksenkende Therapie mit einem beta-Rezeptorenblocker. Dsch Med Wschr 1993; 118: 535-40.
66. Krayenbuehl HP, Hess OM, Monrad ES, Schneider J, Mall G, Turina M. Function and structure of the failing left ventricular myocardium in aortic valve disease before and after valve replacement. Basic Res Cardiol 1991; 86 (Suppl 3): 175-85.
67. MacMahon SW, Wilcken DEL, MacDonald GJ. The effect of weight reduction on left ventricular mass. A randomized trial in young, overweight patients. N Engl Med 1986; 314: 334-9.
68. Neaton JD, Grimm RH, Prieas RJ, et al. Treatment of Mild Hypertension Study. Final results. JAMA 1993; 270: 713-24.
69. Weber KT, Brilla CG. Pathological hypertrophy and the cardiac interstitium: fibrosis and the renin-angiotensin-aldosterone system. Circulation 1991; 83: 1849-65.
70. Bauwens F, Duprez D, De Buyzere, et al. Influence of the arterial blood blood pressure and non-hemodynamic factors on left ventricular hypertrophy in moderate essential hypertension. Am J Cardiol 1991; 68: 925-9.
71. Duprez D, Bauwens F, De Buyzere M, et al. Influence of arterial blood pressure and aldosterone on left ventricular hypertrophy in essential hypertension. Am J Cardiol 1993; 71: 1A-4.
72. Sen S, Tarazi RC, Bumpus FM. Cardiac hypertrophy and antihypertensive therapy. Cardiovasc Res 1977; 11: 427-33.
73. Brilla CG, Janicki JS, Weber KT. Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy. Circulation 1991; 83: 1771-9.
74. Sen S, Bumpus FM. Collagen synthesis in development and reversal of cardiac hypertrophy in spontaneously hypertensive rats. Am J Cardiol 1979; 44: 954-8.
75. Motz W, Strauer BE. Left ventricular function and collagen content after regression of hypertensive hypertrophy. Hypertension 1989; 13: 43-50.
76. Dahlöf B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies. Am J Hypertens 1992; 5: 95-110.
77. Devereux RD, Dahlöf B. Criteria for an informative trial of left ventricular hypertrophy regression. J Hum Hypertens 1994; 8: 735-9.
78. Cruickshank JM, Lewis J, Moore V, Dodd C. Reversibility of left ventricular hypertrophy by differing types of antihypertensive therapy. J Hum Hypertens 1992; 6: 85-90.
79. Otterstad JE, Froeland G, Wasenius Soeyland AK, Knutsen KM, Ekeli T. Changes in left ventricular dimensions and systolic function in 100 mildly hypertensive men during one year's treatment with atenolol vs, hydrochlorothiazide and amiloride (Moduretic): a double blind, randomized study. J Intern Med 1992; 211: 493-50.
80. Saunders E. Drug treatment considerations for the black hypertensive patient. J Fam Pract 1988; 26: 659-64.
81. Schulman SP, Weiss JL, Becker LC, et al. The effects of antihypertensive therapy on left ventricular mass in elderly patients. New Engl J Med 1990; 320: 1350-6.
82. Yerenev AP, Dyakonova HG, Novikov ID, et al. Management of essential hypertension in patients with different degrees of left ventricular hypertrophy. Multicenter trial. Am J Hypertens 1992; 5: 182S-9.
83. Koren MJ, Savage DD, Casale PN, Laragh JH, Devereux RB. Changes in left ventricular mass predict risk in essential hypertension. Circulation 1990; 82(abstract): III-29.
84. Levy D, Salomon M, D'Agostino, Belanger AJ, Kannel WB. Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. Circulation 1994; 90: 1786-93.
85. Liebson PR, Grandits GA, Dianzumba S, et al. Comparison of five antihypertensive monotherapies and placebo for change in left ventricular mass in patients receiving nutritional-hygienic therapy in the treatment of mild hypertension study (TOMHS). Circulation 1995; 91: 698-706.
86. Shahi M, Thom S, Poulter N, Sever PS, Foale RA. Regression of hypertensive left ventricular hypertrophy and left ventricular function. Lancet 1990; 336: 458-61.
87. Mayet J, Shahi M, Foale RA, Poulter N, Sever PS, Thom S. Left ventricular function in hypertension: A four year follow-up study. Circulation 1993; 88(abstract): I-169
88. Kjeldsen SE, Gupta RK, Krause L, Weder AB, Julius S. Does blood pressure reduction necessarily compromise cardiac function or renal hemodynamics? Effects of the angiotensin-converting enzyme inhibitor quinapril. Am Heart J 1992; 123: 1433-8.